http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2291429-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c1ee62deaac38b56b38648135a89eac |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2005-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7961a7b41ff2dc501885f9d54210b7fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f47f83e4ddc977ed573931065ae2f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fc81aa2ce0874def77ed938f529d93f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b64a724874db7302e4f73fdfe1acc1b7 |
| publicationDate | 2007-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2291429-C1 |
| titleOfInvention | Method for predicting corneal subepithelial fibroplasia development after photorefractive excimer laser keratectomy |
| abstract | FIELD: medicine. n SUBSTANCE: method involves determining total antitripsin activity in excimer reactive substances concentration in lacrimal fluid concentration in lacrimal fluid before operation. The value being less than 13.2 nmole/min/ml, corneal subepithelial fibroplasia development is to be predicted after the operation. n EFFECT: high accuracy of prognosis. n 2 dwg |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2782132-C1 |
| priorityDate | 2005-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.